Oxylent SRL
The score of Oxylent shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -80 % Total assets -69 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oxylent's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 08 Aug 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
Oxylent's financial analysis
- Solvency19.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oxylent
Oxylent's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0844.539.012
- VAT number
- BE0844539012
- Peppol
- Registered · 0208:0844539012 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Mar 2012
- Registered office
- 7822 Ath
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Oxylent (SRL) has been based in Ath since 2012, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 2,956 € and equity of 18,578 €; its revenue is not published. Its solvency stands at 19.0%, below the median of its sector (58.2%).
Companies similar to Oxylent
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Matteriall Research and experimental development on natural sciences and engineering Leuven · balance sheet 104,898 €
- Mulltron Research and experimental development on natural sciences and engineering Antwerp · balance sheet 80,357 €
- Recherche ET Sante Research and experimental development on natural sciences and engineering Waterloo · balance sheet 75,174 €
- Innovative Microbial Bioprocess Research and experimental development on natural sciences and engineering Anderlecht · balance sheet 131,307 €
- Ecovic Research and experimental development on natural sciences and engineering Heusden-Zolder · balance sheet 141,287 €
Frequently asked questions about Oxylent
What is the revenue of Oxylent?
Oxylent files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oxylent?
In Belgium, the VAT number is the company number prefixed with BE: BE0844539012 for Oxylent, if the company is VAT-registered. Its company number (CBE) is 0844.539.012.
Where is the registered office of Oxylent?
According to the CBE register, the registered office of Oxylent is in 7822 Ath.
What is the equity of Oxylent?
At the close of the 2025 financial year, the equity of Oxylent amounts to 18,578 €, a solvency of 19.0% of total assets.
Who manages Oxylent?
The register lists 1 active mandates at Oxylent. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oxylent
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →